SHEHNAZ NARULA: Open Payments
NPI 1538795877 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 12 payments from 11 companies in 2025. Trend: 2023 $503 · 2024 $803 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $142 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Amarin Pharma, Inc. | 1 | $113 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: WATCHMAN FLX, Auvelity, DAYBUE, CRYSVITA, AUSTEDO XR, Vascepa, SHINGRIX, Kerendia.
Industry payments across TX — which companies pay providers there.
